Politician trade (House)

Boston Scientific (BSX): Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a partial sale $1K–$15K

Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a partial sale of Boston Scientific in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
21 days
Disclosure lag
Traded
Mar 17, 2025
Disclosed
Apr 7, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 3, 2024InsiderOfficer purchased ~$4.5K of BSX shares in the open market
  2. Dec 10, 2024InsiderOfficer sold ~$1.8K of BSX shares in the open market
  3. Feb 3, 2025Insider · 1 personInsiders: 2 sales (~$1.8M)
  4. Feb 7, 2025InsiderOfficer sold ~$685K of BSX shares in the open market
  5. Feb 11, 2025InsiderDirector sold ~$1.27M of BSX shares in the open market
  6. Feb 12, 2025Insider · 3 peopleInsiders: 3 sales (~$3.6M)
  7. Feb 13, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  8. Feb 14, 2025InsiderOfficer sold ~$128K of BSX shares in the open market
  9. Feb 18, 2025Insider · 2 peopleInsiders: 3 sales (~$2.1M)
  10. Feb 19, 2025Insider · 3 peopleInsiders: 3 sales (~$7.6M)
  11. Feb 21, 2025InsiderOfficer sold ~$505K of BSX shares in the open market
  12. Feb 24, 2025Insider · 2 peopleInsiders: 2 sales (~$1.9M)
  13. Feb 24, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  14. Feb 25, 2025InsiderOfficer sold ~$280K of BSX shares in the open market
  15. Feb 28, 2025InsiderOfficer sold ~$1M of BSX shares in the open market
  16. Mar 3, 2025InsiderOfficer sold ~$750K of BSX shares in the open market
  17. Mar 3, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  18. Mar 4, 2025InsiderOfficer sold ~$50K of BSX shares in the open market
  19. Mar 17, 2025 · this disclosureCongressDisclosed partial sale of BSX — reported range $1,001 - $15,000

What came next

  1. Mar 21, 2025InsiderOfficer sold ~$487K of BSX shares in the open market
  2. Apr 1, 2025InsiderCEO sold ~$16.4M of BSX shares in the open market
  3. Apr 15, 2025FDAFDA device clearance: Percuflex Ureteral Stent; Percuflex Plus Ureteral Stent; Percuflex Plus SureDrive Steerable Ureteral Stent Set; Contour Ureteral Stent; Contour SureDrive Steer…
  4. Apr 21, 2025InsiderOfficer sold ~$459K of BSX shares in the open market
  5. Apr 21, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
  6. Apr 28, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  7. May 1, 2025Insider · 2 peopleInsiders: 3 sales (~$18.6M)
  8. May 5, 2025InsiderOfficer sold ~$478K of BSX shares in the open market
  9. May 12, 2025CongressDisclosed sale of BSX — reported range $15,001 - $50,000
  10. May 13, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  11. May 21, 2025InsiderOfficer sold ~$514K of BSX shares in the open market
  12. May 28, 2025FDAFDA device clearance: OptiMap™ System
  13. May 29, 2025InsiderDirector sold ~$418K of BSX shares in the open market
  14. Jun 2, 2025Insider · 1 personInsiders: 2 sales (~$17.1M)
  15. Jun 4, 2025InsiderOfficer sold ~$5.8M of BSX shares in the open market
  16. Jun 6, 2025FDARecall: Superion IDS Kit Superion Indirect Decompression System 8MM, VF Implant 101-9808 00884662000529 Superion Indirect Decompression System 10MM, VF Implant 101-981…
  17. Jun 10, 2025FDARecall: Torflex Transseptal Guiding Sheath Kit (TFK-M) TF85-32-63-45 TORFLEX 8.5F 63CM 45DEG TF85-32-63-55 TORFLEX 8.5F 63CM 55DEG Used for the percutaneous introducti…
  18. Jun 10, 2025FDARecall: VersaCross Access Solution (VXSK), Product Description and ID: VXSK (180J RF WIRE 63CM/45DEG/D0) VXSK0101 VXSK (180J RF WIRE 63CM/45DEG/D1) VXSK0102 VXSK (180J…
  19. Jun 10, 2025FDARecall: VersaCross RF Wire (VXW). Indicated for creation of an atrial septal defect in the heart. Product ID VXW0002 Device approved and commercialized in Japan only.
  20. Jun 10, 2025FDARecall: VersaCross Transseptal Sheath Kit (VXS) Product Description/IDs VXS0201 VXS 63CM/45DEG/D0 SHEATH VXS2112 VERSACROSS SHEATH (63CM 45DEG D0)-J Used for the percu…
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Rep. Gilbert Ray Cisneros Jr. (CA31)

The full history of Rep. Gilbert Ray Cisneros Jr. (CA31) is on the profile page.

How this filing works

Explore the data

Common questions

Which member of Congress traded Boston Scientific (BSX) stock, and how much?

Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a partial sale of Boston Scientific in the $1K–$15K range. Reported range, not an exact amount.

When did it happen, and when was it made public?

Traded: Mar 17, 2025. Disclosed: Apr 7, 2025. That is 21 days between the two dates.

Why is the amount a range and not an exact figure?

Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.

Where does this information come from?

From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Boston Scientific recently?

For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.

Does this mean BSX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data